JP2020528462A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020528462A5 JP2020528462A5 JP2020526709A JP2020526709A JP2020528462A5 JP 2020528462 A5 JP2020528462 A5 JP 2020528462A5 JP 2020526709 A JP2020526709 A JP 2020526709A JP 2020526709 A JP2020526709 A JP 2020526709A JP 2020528462 A5 JP2020528462 A5 JP 2020528462A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- weight
- magnesium
- combination
- feverfew
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 8
- 229910052749 magnesium Inorganic materials 0.000 claims 8
- 239000011777 magnesium Substances 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 5
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims 4
- 239000000395 magnesium oxide Substances 0.000 claims 4
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical group [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims 4
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims 3
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims 3
- 241000196324 Embryophyta Species 0.000 claims 3
- 206010019233 Headaches Diseases 0.000 claims 3
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 claims 3
- 240000004460 Tanacetum coccineum Species 0.000 claims 3
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 claims 3
- 235000008384 feverfew Nutrition 0.000 claims 3
- 229940001448 feverfew extract Drugs 0.000 claims 3
- 235000020702 feverfew extract Nutrition 0.000 claims 3
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 claims 3
- 229940120668 salicin Drugs 0.000 claims 3
- 231100000869 headache Toxicity 0.000 claims 2
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 claims 1
- 208000006561 Cluster Headache Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- BUQLXKSONWUQAC-UHFFFAOYSA-N Parthenolide Natural products CC1C2OC(=O)C(=C)C2CCC(=C/CCC1(C)O)C BUQLXKSONWUQAC-UHFFFAOYSA-N 0.000 claims 1
- 206010043269 Tension headache Diseases 0.000 claims 1
- 208000008548 Tension-Type Headache Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- KTEXNACQROZXEV-PVLRGYAZSA-N parthenolide Chemical compound C1CC(/C)=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 KTEXNACQROZXEV-PVLRGYAZSA-N 0.000 claims 1
- 229940069510 parthenolide Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024025829A JP2024061731A (ja) | 2017-07-26 | 2024-02-22 | 片頭痛の予防及び治療に使用するための栄養補助食品 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000085185A IT201700085185A1 (it) | 2017-07-26 | 2017-07-26 | Integratore alimentare per uso come coadiuvante nel trattamento e profilassi dell’emicrania |
| IT102017000085185 | 2017-07-26 | ||
| PCT/IB2018/055454 WO2019021148A1 (en) | 2017-07-26 | 2018-07-23 | FOOD SUPPLEMENTS FOR USE IN THE PROPHYLAXIS AND TREATMENT OF MIGRAINE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024025829A Division JP2024061731A (ja) | 2017-07-26 | 2024-02-22 | 片頭痛の予防及び治療に使用するための栄養補助食品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020528462A JP2020528462A (ja) | 2020-09-24 |
| JP2020528462A5 true JP2020528462A5 (https=) | 2021-09-02 |
Family
ID=60451071
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526709A Withdrawn JP2020528462A (ja) | 2017-07-26 | 2018-07-23 | 片頭痛の予防及び治療に使用するための栄養補助食品 |
| JP2024025829A Pending JP2024061731A (ja) | 2017-07-26 | 2024-02-22 | 片頭痛の予防及び治療に使用するための栄養補助食品 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024025829A Pending JP2024061731A (ja) | 2017-07-26 | 2024-02-22 | 片頭痛の予防及び治療に使用するための栄養補助食品 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11458160B2 (https=) |
| EP (1) | EP3657964B1 (https=) |
| JP (2) | JP2020528462A (https=) |
| CN (2) | CN118203111A (https=) |
| CA (1) | CA3069285A1 (https=) |
| DK (1) | DK3657964T3 (https=) |
| ES (1) | ES2917975T3 (https=) |
| HU (1) | HUE059251T2 (https=) |
| IT (1) | IT201700085185A1 (https=) |
| PL (1) | PL3657964T3 (https=) |
| PT (1) | PT3657964T (https=) |
| WO (1) | WO2019021148A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023086266A (ja) * | 2021-12-10 | 2023-06-22 | 日本メナード化粧品株式会社 | 血流改善剤 |
| JP2023135861A (ja) * | 2022-03-16 | 2023-09-29 | 味の素株式会社 | 塩味増強用組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2141126A1 (en) * | 1995-01-26 | 1996-07-27 | Natalie J. Lazarowych | Combinational drug for treating migraine and other illnesses |
| AU1930897A (en) * | 1997-03-03 | 1998-09-22 | Laboratoires Remilea | Plant extract compositions, method of preparation, and pharmaceutical comp ositions containing them |
| US6068999A (en) * | 1998-06-25 | 2000-05-30 | Hendrix; Curt | Dietary supplement for supporting cerebrovascular tone and treating migraine headaches |
| US6312736B1 (en) * | 1999-12-09 | 2001-11-06 | Biotech Corporation | Herbal composition to relieve pain |
| US6770263B1 (en) * | 2001-10-01 | 2004-08-03 | Naturewell, Incorporated | Compositions and methods for the treatment of aches and pains |
| US20080206360A1 (en) * | 2004-12-01 | 2008-08-28 | Curt Hendrix | Folate based migraine treatment |
| US20060233892A1 (en) * | 2005-04-19 | 2006-10-19 | Curt Hendrix | Topiramate compositions for treatment of headache |
| CN101156935A (zh) * | 2007-03-12 | 2008-04-09 | 北京联合伟华药业有限公司 | 治疗偏头痛的植物活性成分组合物及其制备方法和应用 |
| US20100284986A1 (en) * | 2009-05-06 | 2010-11-11 | Kelleher Kevin J | Compositions and methods for prevention and treatment of migraines |
| US20130028985A1 (en) * | 2011-07-25 | 2013-01-31 | Greene Donald J | Composition and method for treating migraines |
-
2017
- 2017-07-26 IT IT102017000085185A patent/IT201700085185A1/it unknown
-
2018
- 2018-07-23 PL PL18753247.8T patent/PL3657964T3/pl unknown
- 2018-07-23 CA CA3069285A patent/CA3069285A1/en active Pending
- 2018-07-23 CN CN202410371868.6A patent/CN118203111A/zh active Pending
- 2018-07-23 CN CN201880048234.XA patent/CN111031814A/zh active Pending
- 2018-07-23 ES ES18753247T patent/ES2917975T3/es active Active
- 2018-07-23 PT PT187532478T patent/PT3657964T/pt unknown
- 2018-07-23 DK DK18753247.8T patent/DK3657964T3/da active
- 2018-07-23 JP JP2020526709A patent/JP2020528462A/ja not_active Withdrawn
- 2018-07-23 US US16/633,280 patent/US11458160B2/en active Active
- 2018-07-23 WO PCT/IB2018/055454 patent/WO2019021148A1/en not_active Ceased
- 2018-07-23 EP EP18753247.8A patent/EP3657964B1/en active Active
- 2018-07-23 HU HUE18753247A patent/HUE059251T2/hu unknown
-
2024
- 2024-02-22 JP JP2024025829A patent/JP2024061731A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Augusti et al. | Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: Implications for COVID-19 | |
| Inoue et al. | Low and medium but not high doses of green tea polyphenols ameliorated dextran sodium sulfate-induced hepatotoxicity and nephrotoxicity | |
| Sharma et al. | Antidiarrhoeal activity of leaf extract of Celosia argentea in experimentally induced diarrhoea in rats | |
| RU2015139742A (ru) | Селенсодержащие композиции и их применение для лечения и предотвращения заболеваний или состояний, связанных с митохондриальной дисфункцией | |
| JP2016530291A5 (https=) | ||
| RU2017116740A (ru) | Комбинации для лечения рассеянного склероза | |
| EP2578214A4 (en) | PHARMACEUTICAL COMPOSITION WITH RAMALIN FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY OR IMMUNE DISEASES | |
| JP2007508326A5 (https=) | ||
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| JP2020523374A5 (https=) | ||
| JP2020528462A5 (https=) | ||
| WO2018108931A3 (en) | Nutritional compositions containing butyrate and/or lactoferrin and uses thereof | |
| BR112021018169A2 (pt) | Composto para o controle de diabetes de felinos | |
| MX2025008288A (es) | Cepas probioticas capaces de inhibir fusobacterium necrophorum y mejorar la integridad de la barrera intestinal | |
| CN110520135A (zh) | 维生素组合物在制备用于预防、治疗或延迟阿尔茨海默病的药物中的用途 | |
| MX2023000899A (es) | Administracion de beta-hidroxibutirato y compuestos relacionados en humanos para el tratamiento y/o prevencion de enfermedades respiratorias. | |
| JP2018529763A5 (https=) | ||
| JP2023181419A5 (https=) | ||
| Anteneh et al. | Acute oral toxicity test from leaf exudates of 17 Aloe species from east and south of the great rift valley in Ethiopia | |
| WO2011163321A3 (en) | Composition and method of treating lipid encapsulated virus infections | |
| CN106265943A (zh) | 一种治咽喉干燥灼热的配方 | |
| CN106552046A (zh) | 一种治声带混浊嘶哑的配方 | |
| PH12018502090A1 (en) | Unit doses for immediate release of ghb or of one of the therapeutically acceptable salts thereof, administered orally, and the use thereof to maintain alcohol abstinence | |
| KRAIPHET et al. | Effects of Moringa oelifera Lam. pod on the apoptosis induction in mouse colon carcinoma | |
| CN105663242A (zh) | 一种针对慢性单纯性鼻炎的食疗配方 |